Your browser doesn't support javascript.
loading
Role of nodal skip metastasis in patients with mid-thoracic oesophageal squamous cell carcinoma: a propensity score matching study.
Xu, Zhi-Jie; Zhuo, Ze-Guo; Song, Tie-Niu; Alai, Gu-Ha; Shen, Xu; Yao, Peng-; Lin, Yi-Dan.
Afiliación
  • Xu ZJ; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Zhuo ZG; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Song TN; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Alai GH; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Shen X; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Yao P; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Lin YD; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
Eur J Cardiothorac Surg ; 59(4): 799-806, 2021 04 29.
Article en En | MEDLINE | ID: mdl-33249483
ABSTRACT

OBJECTIVES:

Nodal skip metastasis (NSM) is a common phenomenon in mid-thoracic oesophageal squamous cell carcinoma (MT-OSCC); however, the prognostic implications of NSM in patients with MT-OSCC remain unclear.

METHODS:

This retrospective study enrolled 300 patients with MT-OSCC who underwent radical oesophagectomy and who had pathologically confirmed lymph node metastasis from January 2014 to December 2016. The patients were divided into 2 groups according to the presence or absence of NSM. Propensity score matching was applied to minimize patient selection bias. The impact of NSM on overall survival (OS) was assessed by Kaplan-Meier and multiple Cox proportional hazards analyses. The median follow-up time was 57 months.

RESULTS:

The NSM rate in the entire cohort was 22.0% (66/300). Pathological N (pN) stage (P < 0.001) and sex (P = 0.001) were identified as significant independent risk factors for NSM. NSM was more frequent in pN1 compared with pN2 patients (87.9% vs 12.1%, P < 0.001) and no NSM was found in pN3. NSM(+) patients had better prognoses than NSM(-) patients (Kaplan-Meier; 3-year OS, 62.1% vs 34.1%, P < 0.001). Propensity score matching produced 51 matched pairs, and the 3-year OS was still better in the NSM(+) compared with the NSM(-) group (66.7% vs 40.0%, P = 0.025). Multivariable Cox analysis confirmed NSM(+) as an independent factor favouring OS in patients with MT-OSCC.

CONCLUSIONS:

NSM usually occurs at pN1 stage in patients with MT-OSCC, and is associated with a favourable prognosis.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas de Esófago Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Cardiothorac Surg Asunto de la revista: CARDIOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas de Esófago Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Cardiothorac Surg Asunto de la revista: CARDIOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China